Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Arch. med. res ; 27(1): 57-62, 1996. tab, ilus
Article in English | LILACS | ID: lil-200291

ABSTRACT

We report the frequency of the finding of storage and hemophagocytic histiocytes in the bone marrow of patients with systemic lupus erythematosus with one or more hemocytopenias. The study was performed on bone marrows of ten patients with systemic lupus erythematosus during an episode of hemocytopenia. Four patients were not receiving any treatment and six had been takin oral prednisone (3.5 ñ 1.5 mg/day) for the previous 6 months. Hemocytopenia found were lymphocytopenia in five, thrombocytopenia in three, and neutropenia and anemia in two each. The bone marrow had variable cell content; megakaryocytes, the myeloid:erythroid ratio, as well as lymphocyte, plasma cell, and reticular cell contents were usually increased. Seven bone marrow samples showed storage distiocytes (sea-blue histiocytes and other histiocytes that contained unidentified intracytoplasmic material). These same samples revealed histiocytes phagocytosing erythoblasts, erythrocytes, polymorphonuclear neutrophils, lymphocytes in all seven patients was related to a decrease in serum complement and with lupus disease activity as mesured with the SLEDAI index (X ñ SD = 2.1 ñ 1.5). The SLEDAI score of the remaining three patients, who had no histiocytes in their bone marrow, was 0, 0, and 1, respectively. the present study reveals that the bone marrow in patients with systemic lupus erythematosus and peripheral hemocytopenia contains storage and hemophagocytic histiocytes and the significance of these cells is discussed


Subject(s)
Humans , Bone Marrow , Clinical Laboratory Techniques , Histiocytes/metabolism , Lupus Erythematosus, Systemic/physiopathology , Prednisone/therapeutic use
2.
An. bras. dermatol ; 67(2): 61-4, 65-6, mar.-abril.1992.
Article in Portuguese | LILACS | ID: lil-113109

ABSTRACT

Os autores fazem uma revisäo histórica da hanseníase e sua magnitude no Brasil. Apresentam revisäo atualizada da imunopatia, genética e suas expressöes clínicas na classificaçäo, dando especial enfoque a seus conceitos sobre hanseníase virchowiana e os estados reacionais qeu nela incidem


Subject(s)
Humans , Male , Leprosy/history , Lepromin/immunology , Collagen Diseases/etiology , Leprosy/classification , Leprosy/epidemiology , Histiocytes/metabolism , Leprosy, Lepromatous/complications , Leprosy, Tuberculoid , Mycobacterium leprae/isolation & purification
3.
Yonsei Medical Journal ; : 11-16, 1988.
Article in English | WPRIM | ID: wpr-20081

ABSTRACT

ln an attempt to clarify the dual origin histiocytes and to reclassify histiocytic proliferative disorders according to their immunohistochemical properties, normal histiocytes and histiocytes in selected proliferative disorders were stained using the peroxidase-antiperoxidase method for lysozyme, 1-antichymotrypsin and for S-100 protein. The proliferated histocytes of cosinophilic granutoma and Letterer-siwe disease were strongly immunoreactive for S-100 protein. In histiocytic medullary reticulosis (HMR) and in histiocytic lymphoma, all three markers were found within the tumor cells. ln fibrous histiocytoma and in juvenile xanthogranuloma, only a few weakly immunoreactive cells for S-100 protein were observed. lnflammatory malignant fibrous histiocytoma(MFH) (Xanthosarcoma) and xanthoma were immunoreactive for 1-antichymotrypsin and lysozyme respectively. ln MFH of the storiform -pleomorphic type and in atypical fibroxanthoma, stains using all of the histiocytic markers were negative. These results suggest that eosinophilic granuloma. Letterer-Siew disease, fibroxanthoma and juvenile xanthogranloma are proliferative disorder of T-zone histiocytes; HMR and histiocytic lymphoma are those of pluripotential stem cells capable of dual histiocytic differentiation; xanthoma and xanthosarcoma are monocytic proliferative disease; and MFH of the storiform-pleomorphic type and atypical fibroxanthoma are not true histiocytic diseases.


Subject(s)
Humans , Histiocytes/metabolism , Immunohistochemistry , Lymphatic Diseases/classification , S100 Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL